RHEACELL GmbH & Co. KG jobs and careers

About RHEACELL GmbH & Co. KG

RHEACELL is a late-stage biopharmaceutical company focused on transforming the treatment of severe inflammation-driven diseases with significant unmet medical need. Our proprietary ABCB5⁺ mesenchymal stromal cell (MSC) platform, exclusively licensed from Children’s Medical Center (CMCC), Harvard Medical School, addresses the root cause of chronic and systemic inflammation, enabling tissue regeneration, neovascularization, and durable healing. RHEACELL has achieved a key value-inflection point with national market approval in Germany (Paul-Ehrlich-Institute, 2021) for our ABCB5⁺ MSC therapy in non-healing chronic venous ulcers, providing strong clinical and regulatory validation of our technology. With a first- and best-in-class profile, differentiated mode of action, and both topical and systemic (intravenous) applications, our therapies target internal and external wounds, reduce overall disease burden, and aim to prevent recurrence. RHEACELL combines deep scientific expertise with proven clinical execution, maintaining full control of the value chain from preclinical development through pivotal Phase III trials, positioning the company for scalable growth and strategic partnering. 🤝As of November 1, 2025, AOP Health assumed the role of marketing authorization holder and took over the distribution of AMESANAR®. 🔗 Privacy Policy: https://www.rheacell.com/en/privacy-policy/